Compare GIXI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIXI | GDTC |
|---|---|---|
| Founded | 1978 | 2018 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.4M |
| IPO Year | N/A | 2021 |
| Metric | GIXI | GDTC |
|---|---|---|
| Price | $4.05 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 16.8K |
| Earning Date | 11-30-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.56 | $0.68 |
| 52 Week High | $8.34 | $3.10 |
| Indicator | GIXI | GDTC |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 50.22 |
| Support Level | $3.79 | $0.73 |
| Resistance Level | $8.34 | $1.07 |
| Average True Range (ATR) | 0.72 | 0.11 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 7.53 | 53.71 |
Gix Internet Ltd provides infrastructure for managing and authorizing autonomous systems, including autonomous mobile robots (AMRs), automated guided vehicles (AGVs), humanoid robots, robotaxis, shuttles, drones, and human workforces. The company's platform provides: mission generation and orchestration across mixed-fleet environments; real-time authorization and policy-gate enforcement for regulatory compliance; and cryptographically signed records of authorized actions for regulatory compliance.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.